placeholder image
J. S. Perlmutter All authors
Publications While At HealthPartners
selected publications
Journal Article
  • End-of-life measures in Huntington disease: HDQLIFE meaning and purpose, concern with death and dying, and end of life planning
    Journal of Neurology. 2019
  • A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning
    Journal of Neurology. 2018
  • Agreement between clinician-rated versus patient-reported outcomes in Huntington disease
    Journal of Neurology. 2018
  • Relationships among apathy, health-related quality of life, and function in Huntington's disease
    Journal of Neuropsychiatry and Clinical Neurosciences. 2018
  • A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
    Neurology. 2017
  • Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS): implications for clinical trials
    JAMA neurology. 2016
  • HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)
    Quality of Life Research. 2016
  • HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, speech difficulties, and swallowing difficulties
    Quality of Life Research. 2016
  • New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system)
    Quality of Life Research. 2016
  • Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study
    Neurology. 2008
  • Replication of association between ELAVL4 and Parkinson disease: the GenePD study
    Human Genetics. 2008
  • The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    BMC Medicine. 2008
  • Contact
    full name
  • J. S. Perlmutter
  • Quick Info